The Research that Led to the First Alzheimers Treatment
Join Dr. Jason Karlawish from Penn Medicine as he discusses groundbreaking research in understanding and diagnosing dementia and cognitive impairments. Learn how cutting-edge technologies like MRI, PET scans, and spinal fluid analysis are revolutionizing our approach to neurodegenerative diseases.
Dr. Karlawish explains how these advancements allow for:
Precise diagnosis of current cognitive impairments
Early detection of future risks
A shift from post-mortem to real-time diagnosis
Discover Penn's role in the biomarker revolution and Dr. Karlawish's vision for the future – a world where at-risk individuals receive personalized care, maintain engagement in life, and have access to treatments that reduce risks and improve quality of life.
This video offers hope and insight into the transformative work being done at Penn Medicine to combat cognitive decline and support those affected by these conditions.
#pennmedicine #DementiaResearch #PennMedicine #CognitiveHealth #Neuroscience
